Figure 1.
Comprasion of Marker-Positive Cells in the infrapatellar fat pad (IPFP) and abdominal subcutaneous adipose tissue (SCAT)
Table 1.
The relative number of cells expressing CD44+, CD166+, SOX9+ in the biopsy material of infrapatellar fat pad (IPFP) and abdominal subcutaneous adipose tissue (SCAT)
| GROUP | MARKER | ME (%) | Q1 (%) | Q3 (%) | IQR (%) | CV (%) |
|---|---|---|---|---|---|---|
| SCAT | CD166+ | 1.10 | 0.80 | 1.50 | 0.70 | 63.64 |
| CD44+ | 1.40 | 1.00 | 2.00 | 1.00 | 71.43 | |
| Sox9+ | 0.90 | 0.60 | 1.20 | 0.60 | 66.67 | |
| IPFP | CD166+ | 10.34 | 8.22 | 12.78 | 4.56 | 44.10 |
| CD44+ | 13.28 | 8.57 | 15.11 | 6.54 | 49.25 | |
| Sox9+ | 7.30 | 6.71 | 8.02 | 1.31 | 17.95 |
Figure 2.
Immunohistochemical staining of biopsy samples from infrapatellar fat pad showing expression of CD44, CD166, and SOX9 markers (brown staining). Arrows